Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2015 / May / Ocular Ebola Threat
Microbiology & Immunology Microbiology and Immunology Infectious Disease

Ocular Ebola Threat

By Roisin McGuigan 05/22/2015 1 min read

Share

Health worker’s ocular fluid tests positive for Ebola months after virus became undetectable in blood

A doctor working in West Africa was found to have the Ebola virus in the aqueous humor of his left eye 10 weeks after it was no longer detectable in his blood, and developed severe uveitis which threatened his vision – a finding which could have far-reaching implications for survivors of the recent Ebola outbreak.

Ian Crozier, an infectious disease specialist, contracted Ebola while helping to fight the epidemic in Sierra Leone in August 2014, and within a few weeks had contracted the virus and was evacuated to Emory University Hospital in Atlanta, USA. After spending some time in a critical condition he began to recover and was discharged. However, he then began to develop symptoms of ocular disease, including pain and intolerance to light, which progressed to blurred and decreasing vision. His aqueous humor tested positive for the Ebola virus using quantitative real-time PCR, despite the surface of the eye, the tear film and peripheral blood samples remaining negative for the virus. The resulting case study (1) reports that the pathology of ocular Ebola infection is unknown, but the researchers involved theorize that the severe uveitis observed was a direct cytopathic effect of the virus. “The presence of viable Ebola virus in the eye could mean that other Ebola survivors may also be at risk for the development of uveitis,” says Steven Yeh of the Emory Eye Center. “The thousands of Ebola survivors in West Africa and healthcare workers in their home countries will need to be monitored for eye disease in the post-Ebola period.”

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. JB Varkey et al., “Persistence of Ebola virus in ocular fluid during convalescence”, N Engl J Med, [Epub ahead of print] (2015). PMID: 25950269.

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.